Latin America Bone Graft and Substitutes Market, by Product Type (Bone graft (Allografts and Xenografts) and Bone Graft Substitutes (Ceramics, Composites, Polymers, Bone Morphogenetics Proteins, and Others)), by Application (Spinal Fusion, Dental Bone Grafts, Craniomaxillofacial, Joint Reconstruction, and Trauma), and by Country (Colombia, Peru, Chile, and Rest of Latin America) was valued at US$ 116.8 million in 2018, and is projected to exhibit a CAGR of 5.8%, during the forecast period (2018 - 2026).
A bone graft substitute is osteoinductive, biocompatible, bioresorbable, and structurally similar to bone and is easy to use and cost-effective. Bone graft substitutes are used in dental implants, fibular shaft, and others. The properties of bone grafts includes osteoconduction, osteogenesis, osteopromotion, and osteoinduction. These are the biological mechanisms that provide a basis for bone grafting. Major players in the market are focused on development of innovative bone grafts, which is contributing to growth of Latin America bone graft and substitutes market. For instance, in September 2018, NuVasive, Inc. launched three new biologics products including traditional bone allograft, amniotic membrane DS, and additional form factors to the current Prope DBM (demineralized bone matrix) product line. In 2016, Zimmer Biomet Holdings, Inc. launched PrimaGen Advanced Allograft, an autograft substitute containing the same bone healing elements as autograft, but without the risks associated with donor site morbidity or harvest site complications. Increasing approvals from healthcare regulatory authorities for innovative bone graft implants is expected to drive the market growth. For instance, in 2018, Zimmer Biomet Holdings, Inc. received U.S. Food and Drugs Administration (FDA) clearance for its Comprehensive Augmented Baseplate, which offers an alternative to bone grafting and eccentric reaming for patients with glenoid defects undergoing shoulder reconstruction.
Browse 16 Market Data Tables and 18 Figures spread through 163 Pages and in-depth TOC on " Latin America Bone Graft and Substitutes Market , by Product Type (Bone graft ( Allografts and Xenografts) and Bone Graft Substitutes (Ceramics, Composites, Polymers, Bone Morphogenetics Proteins, and Others)), by Application (Spinal Fusion, Dental Bone Grafts, Craniomaxillofacial, Joint Reconstruction, and Trauma), and by Country (Colombia, Peru, Chile, and Rest of Latin America) – Country Specific Forecast to 2026"
To know the latest trends and insights related to Latin America Bone Graft and Substitutes Market, click the link below:
Increasing prevalence of orthopedic disorders such as arthritis and osteoporosis is expected to lead to high number of patients opting for joint replacement and spine replacement surgeries. For instance, according to Epidemiology of Osteoporosis in Mexico’s estimation in 2013, 1 in 12 women and 1 in 20 men in Mexico are diagnosed with hip fracture after the age of 50. Moreover, the absolute number of hip fractures in the Mexican population is expected to increase even more in the next decades due to increased life expectancy and the consequent aging of the population. Moreover, increasing healthcare expenditure in Latin American countries such as Chile, Peru, and Colombia is expected to boost growth of the market. For instance, according to the International Trade Administration’s (ITA) estimation, in 2018, Chile’s annual healthcare expenditure accounted for approximately 8% of its GDP. Furthermore, increasing medical tourism in Peru is contributing to growth of the market in Peru. For instance, according to Medical Tourism Association (MTA) in 2015, medical tourism in Peru witnessed significant growth during 2010-2015. Around 250,000 people travel to Peru annually for quality medical treatment at lower cost. Majority of Peru’s medical tourism infrastructure is located in Lima.
Key Takeaways of the Latin America Bone Graft and Substitutes Market: